ArticleOrphanet journal of rare diseases2025
Autoimmune thyroid disease in inborn errors of immunity: a retrospective perspective.
Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAutoimmune thyroid diseases (AITDs) are among the most frequently reported autoimmune manifestations in individuals with inborn errors of immunity (IEIs). While immune dysregulation in IEI is known to predispose patients to autoimmunity, data regarding the prevalence and characteristics of AITD in this population remain limited. This study aimed to assess the frequency of AITD and describe its clinical, serological, ultrasonographic, and immunological features in a cohort of adult IEI patients.
methodsThis retrospective study included 45 adult IEI patients, excluding those with selective IgA deficiency. Demographic, clinical, and immunological data were collected from medical records. AITD diagnosis was based on thyroid-specific autoantibodies, thyroid function tests, and/or ultrasonographic features consistent with thyroiditis. Comparative analyses were conducted between patients with and without AITD.
resultsAITD was identified in 7 patients (15.5%), including 6 with Hashimoto’s thyroiditis (HT) and 1 with seronegative chronic autoimmune thyroiditis (SN-CAT); no cases of Graves’ disease were observed. The majority of patients with AITD were female (85.7%), while only one case occurred in a male (14.3%). No statistically significant sex-based difference in AITD frequency was detected (p = 0.225). Anti-thyroid peroxidase antibodies were positive in 85.7% of AITD patients, and anti-thyroglobulin antibodies in 60.0%. All were euthyroid at evaluation, though 57.1% were receiving L-thyroxine therapy. Non-AITD thyroid abnormalities were present in 12 patients (26.6%), including isolated serology and a solitary thyroid nodule. Compared with non-AITD patients, those with AITD exhibited significantly higher CD16⁺56⁺ NK cell percentages (p = 0.010), while other lymphocyte subsets did not differ. No significant differences were observed regarding sex, IEI phenotype, non-thyroidal autoimmunity, or infection-related complications.
conclusionsIn this adult IEI cohort, HT was the most prevalent autoimmune thyroid condition. Distinct immunological features, particularly increased NK cell frequencies, may reflect underlying immune dysregulation. These findings support systematic thyroid evaluation, even in asymptomatic IEI patients, and emphasize the need for larger, genetically diverse cohorts to validate and expand these observations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.